Literature DB >> 27052231

[Diabetic kidney disease - Update 2016].

Harald Sourij1, Roland Edlinger2, Friedrich Prischl3, Martin Auinger2, Alexandra Kautzky-Willer4, Marcus D Säemann5, Rudolf Prager2, Martin Clodi6, Guntram Schernthaner7, Gert Mayer8, Rainer Oberbauer5, Alexander R Rosenkranz9.   

Abstract

Recent epidemiological evaluations have shown that approximately 5% of all Austrians suffer from diabetes including renal involvement, i. e. 400.000 people in Austria are affected. The risk of start and progression of this disease can be ameliorated by lifestyle interventions as well as optimization of blood pressure and glucose levels. The present article represents the joint recommendations of the Austrian Diabetes Association and the Austrian Society for Nephrology for the prevention and treatment of diabetic kidney disease.

Entities:  

Keywords:  Chronic kidney disease; Diabetic kidney disease; Diabetic nephropathy

Mesh：

Year:  2016        PMID： 27052231     DOI： 10.1007/s00508-016-0992-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  95 in total

1.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

2.  Primary prevention of cardiovascular disease with a Mediterranean diet.

Authors:  Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González
Journal:  N Engl J Med       Date:  2013-02-25       Impact factor: 91.245

3.  Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

Authors:  Ravi Retnakaran; Carole A Cull; Kerensa I Thorne; Amanda I Adler; Rury R Holman
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

4.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

5.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

6.  Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).

Authors:  Carmen A Peralta; Keith C Norris; Suying Li; Tara I Chang; Manjula K Tamura; Stacey E Jolly; George Bakris; Peter A McCullough; Michael Shlipak
Journal:  Arch Intern Med       Date:  2012-01-09

7.  Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.

Authors:  Szu-Chun Hung; Yu-Kang Chang; Jia-Sin Liu; Ko-Lin Kuo; Yu-Hsin Chen; Chih-Cheng Hsu; Der-Cherng Tarng
Journal:  Lancet Diabetes Endocrinol       Date:  2015-06-17       Impact factor: 32.069

8.  Association between LDL-C and risk of myocardial infarction in CKD.

Authors:  Marcello Tonelli; Paul Muntner; Anita Lloyd; Braden Manns; Scott Klarenbach; Neesh Pannu; Matthew James; Brenda Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2013-05-16       Impact factor: 10.121

9.  One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

Authors:  Markolf Hanefeld; Paolo Brunetti; Guntram H Schernthaner; David R Matthews; Bernard H Charbonnel
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  Effects of lowering LDL cholesterol on progression of kidney disease.

Authors:  Richard Haynes; David Lewis; Jonathan Emberson; Christina Reith; Lawrence Agodoa; Alan Cass; Jonathan C Craig; Dick de Zeeuw; Bo Feldt-Rasmussen; Bengt Fellström; Adeera Levin; David C Wheeler; Rob Walker; William G Herrington; Colin Baigent; Martin J Landray
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.